A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Neurodegenerative Disorder
Parkinson's Disease (PD)

Results
Download

Study results

LPS BP43176 Final Results September 2025 Dutch (PDF, 0.7 MB)

LPS BP43176 Final Results September 2025 English (PDF, 0.9 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Study results

LPS BP43176 Final Results September 2025 Dutch (PDF, 0.7 MB)

LPS BP43176 Final Results September 2025 English (PDF, 0.9 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

For the latest version of this information please go to www.forpatients.roche.com